These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29297658)

  • 1. Current perspectives on the use of fetal fibronectin testing in preterm labor diagnosis and management.
    Ruma MS; Bittner KC; Soh CB
    Am J Manag Care; 2017 Dec; 23(19 Suppl):S356-S362. PubMed ID: 29297658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth.
    Barner JC; Petrilla AA; Kang HA; Shen X; Alshehri AM; Sullivan EM; Troeger KA; Richards KM; Blackwell SC
    Am J Manag Care; 2017 Dec; 23(19 Suppl):S363-S370. PubMed ID: 29297659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability and use of fetal fibronectin testing and transvaginal ultrasound for preterm labor evaluation in the United States.
    Ruma MS; Banker WM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8586-8593. PubMed ID: 34648390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in the incidence of threatened preterm labor after implementation of transvaginal ultrasound cervical length universal screening.
    Navathe R; Saccone G; Villani M; Knapp J; Cruz Y; Boelig R; Roman A; Berghella V
    J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1853-1858. PubMed ID: 29303014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Wallwiener D; Schmidt S
    J Perinat Med; 2005; 33(5):383-91. PubMed ID: 16238532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical Evaluation in Pregnancy: Proper Measurement, Evaluation, and Management.
    Wax JR; Cartin A; Pinette MG
    Clin Obstet Gynecol; 2017 Sep; 60(3):608-620. PubMed ID: 28742594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and biochemical screening for the risk of preterm labor.
    Wax JR; Cartin A; Pinette MG
    Clin Lab Med; 2010 Sep; 30(3):693-707. PubMed ID: 20638582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fetal fibronectin in women at risk for preterm delivery.
    Andersen HF
    Clin Obstet Gynecol; 2000 Dec; 43(4):746-58. PubMed ID: 11100292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times?
    Lee GT; Burwick R; Zork N; Kjos S
    J Matern Fetal Neonatal Med; 2013 May; 26(7):706-9. PubMed ID: 23170788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short cervical length dilemma.
    Suhag A; Berghella V
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):241-54. PubMed ID: 26002164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal fibronectin as a biomarker of preterm labor: a review of the literature and advances in its clinical use.
    Foster C; Shennan AH
    Biomark Med; 2014; 8(4):471-84. PubMed ID: 24796611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial.
    Ness A; Visintine J; Ricci E; Berghella V
    Am J Obstet Gynecol; 2007 Oct; 197(4):426.e1-7. PubMed ID: 17904989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
    van Baaren GJ; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HCJ; Spaanderman MEA; Bloemenkamp KWM; Haak MC; Bax CJ; Cornette JMJ; Duvekot JJ; Nij Bijvanck BWA; van Eyck J; Franssen MTM; Sollie KM; Vandenbussche FPHA; Woiski M; Bolte AC; van der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ
    Ultrasound Obstet Gynecol; 2018 May; 51(5):596-603. PubMed ID: 28370518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of preterm labor: the role of the fibronectin and ultrasound cervicometry and their association].
    Di Renzo GC; Giardina I; Coata G; Di Tommaso M; Facchinetti F; Petraglia F; Tranquilli AL; Rizzo N
    Minerva Ginecol; 2011 Dec; 63(6):477-83. PubMed ID: 22036751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.